Total Payments
$3,009
2024 Payments
$330.93
Companies
27
Transactions
178
Medicare Patients
2,191
Medicare Billing
$125,623
Payment Breakdown by Category
Food & Beverage$3,009 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,009 | 178 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $574.00 | 38 | $0 (2024) |
| ABBVIE INC. | $361.60 | 15 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $329.47 | 19 | $0 (2022) |
| Novo Nordisk Inc | $286.42 | 15 | $0 (2024) |
| PFIZER INC. | $274.21 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $233.45 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $168.46 | 12 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $134.62 | 10 | $0 (2022) |
| Amgen Inc. | $101.15 | 5 | $0 (2022) |
| Lilly USA, LLC | $79.07 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.93 | 17 | ABBVIE INC. ($113.72) |
| 2023 | $309.60 | 15 | AbbVie Inc. ($78.90) |
| 2022 | $350.83 | 19 | ABBVIE INC. ($57.78) |
| 2021 | $334.20 | 20 | GlaxoSmithKline, LLC. ($50.15) |
| 2020 | $148.20 | 8 | Abbott Laboratories ($38.45) |
| 2019 | $411.21 | 28 | AstraZeneca Pharmaceuticals LP ($177.47) |
| 2018 | $463.57 | 27 | AstraZeneca Pharmaceuticals LP ($144.09) |
| 2017 | $660.08 | 44 | AstraZeneca Pharmaceuticals LP ($129.74) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: PAIN | ||||||
| 09/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: VACCINE | ||||||
| 09/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: PAIN | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Obesity | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Respiratory | ||||||
| 05/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Obesity | ||||||
| 05/03/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.94 | General |
| 03/12/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: PAIN | ||||||
| 02/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.60 | General |
| 01/30/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: PAIN | ||||||
| 11/29/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: HIV | ||||||
| 11/21/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Diabetes | ||||||
| 09/29/2023 | Merck Sharp & Dohme LLC | VARIVAX (Biological), GARDASIL 9, M-M-R II | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: VACCINE | ||||||
| 08/25/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Obesity | ||||||
| 07/29/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 566 | 701 | $134,610 | $22,144 |
| 2022 | 10 | 539 | 683 | $141,300 | $22,513 |
| 2021 | 11 | 520 | 697 | $123,960 | $42,141 |
| 2020 | 13 | 566 | 716 | $106,610 | $38,824 |
Total Patients
2,191
Total Services
2,797
Medicare Billing
$125,623
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 215 | $51,600 | $7,902 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 98 | $33,320 | $4,782 | 14.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 102 | 102 | $22,560 | $2,638 | 11.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 94 | 94 | $3,760 | $1,767 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 39 | $6,630 | $1,746 | 26.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $6,120 | $677.07 | 11.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $800.00 | $501.92 | 62.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 30 | 46 | $1,150 | $437.92 | 38.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $920.00 | $434.70 | 47.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $650.00 | $407.81 | 62.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 14 | 14 | $700.00 | $366.94 | 52.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,520 | $291.01 | 8.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 18 | 18 | $2,880 | $191.37 | 6.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 124 | 172 | $58,480 | $8,428 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 170 | $40,800 | $7,239 | 17.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 94 | 94 | $3,760 | $1,829 | 48.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 22 | 22 | $5,280 | $1,608 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 31 | $5,270 | $1,237 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $22,280 | $913.79 | 4.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $850.00 | $522.23 | 61.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 37 | 48 | $1,200 | $459.60 | 38.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 17 | 17 | $2,720 | $158.31 | 5.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $660.00 | $118.88 | 18.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 138 | 279 | $66,570 | $15,202 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 107 | 107 | $23,640 | $14,346 | 60.7% |
About Dr. Heidi Dorris, M.D
Dr. Heidi Dorris, M.D is a Internal Medicine healthcare provider based in Wakefield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639175482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heidi Dorris, M.D has received a total of $3,009 in payments from pharmaceutical and medical device companies, with $330.93 received in 2024. These payments were reported across 178 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,009).
As a Medicare-enrolled provider, Dorris has provided services to 2,191 Medicare beneficiaries, totaling 2,797 services with total Medicare billing of $125,623. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Wakefield, RI
- Active Since 06/27/2005
- Last Updated 10/01/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1639175482
Products in Payments
- SYMBICORT (Drug) $292.92
- UBRELVY (Drug) $227.55
- FARXIGA (Drug) $192.95
- TOUJEO (Drug) $121.09
- NURTEC ODT (Drug) $115.40
- Wegovy (Drug) $96.30
- TRELEGY ELLIPTA (Drug) $91.86
- Synthroid (Drug) $91.28
- SOLIQUA (Drug) $86.80
- Saxenda (Drug) $85.59
- JANUVIA (Drug) $73.85
- CHANTIX (Drug) $64.65
- AJOVY (Drug) $57.59
- Repatha (Biological) $53.43
- FreeStyle Libre (Device) $53.42
- ASMANEX (Drug) $48.72
- PREVNAR 20 (Biological) $47.05
- AirDuo Digihaler (Drug) $44.37
- Ozempic (Drug) $44.29
- ELIQUIS (Drug) $41.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wakefield
Dr. Bruce Watrous, M.d, M.D
Internal Medicine — Payments: $9,530
Internal Medicine $9,530
Dr. James Rocco, M.d, M.D
Internal Medicine — Payments: $6,711
Internal Medicine $6,711
Monique Pouliot, D.o, D.O
Internal Medicine — Payments: $3,120
Internal Medicine $3,120
Dr. Nitin Damle, Md, MD
Internal Medicine — Payments: $3,102
Internal Medicine $3,102
Paul Barratt, M.d, M.D
Internal Medicine — Payments: $2,857
Internal Medicine $2,857
Dr. Griffin Reynolds, Md, MD
Internal Medicine — Payments: $2,808
Internal Medicine $2,808